The short answer
Folate status may need review during primidone treatment, particularly if blood counts or symptoms suggest a deficiency. Supplementation should be matched to the diagnosis.
What this answer covers
Folate is the nutrient category; specific treatment evidence concerns folic acid, not automatic equivalence to folinic acid or methylfolate.
- Supplement or preparation
- Folate
- Medication ingredient
- primidone
What is known about primidone
A large epilepsy cohort associated primidone with lower folate levels. Its label also recognizes rare megaloblastic anemia that may respond to folic acid.
Check the cause before treating
Primidone was also associated with lower B12 in the cohort. Abnormal blood counts or symptoms need clinical assessment so the appropriate vitamin problem is treated.
Keep nutrient forms distinct
Tell the clinician whether your product contains folic acid, methylfolate or another form. Evidence for one form does not establish the same interaction or replacement plan for every folate product.
Keep the prescribed medicine steady
Do not stop primidone abruptly or adjust its dose to compensate for a supplement. Sudden withdrawal can provoke serious seizures. Tell the prescriber about new or worsening symptoms and all supplement changes.
Evidence and practical considerations
Timing & monitoring
Exact primidone labeling and cohort evidence support targeted folate assessment and treatment when indicated, not a universal supplement requirement.
- Exact scope
- Folate is the nutrient category; specific treatment evidence concerns folic acid, not automatic equivalence to folinic acid or methylfolate. with Exact oral primidone; parent and metabolites distinguished; no other drug/route assumed equivalent.
- Medication form and route
- oral supplement unless pregnancy section explicitly distinguishes neonatal injection
- Timing or duration
- Preparation, dose and duration determine applicability; chronic nutrition evidence is not a single-dose interaction.
What remains uncertain
- Observational folate association and rare anemia are not proof that all users are deficient. Folate and B12 causes should be distinguished.
Factors that may matter: exact supplement identity; dose; other medicines; clinical indication; baseline nutrition; pregnancy where relevant.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed oral primidone for epilepsy.
Primidone itself and its phenobarbital and PEMA metabolites have anticonvulsant activity. Drowsiness, ataxia and vertigo can occur. Rare megaloblastic anemia may respond to folic acid without stopping therapy. Label advises maternal vitamin K1 around delivery. Abrupt withdrawal can provoke status epilepticus.
How this applies: Exact RxCUI 8691 IN primidone, UNII 13AFD7670Q, oral tablets.
Parent and metabolites are distinct active exposures. Pregnancy label advice is not proof of benefit for routine prenatal vitamin K or a general adult supplement requirement.
Source 2: current product label
medicines.org.uk · Source check Sep 10, 2026
Population: Patients receiving oral primidone for epilepsy or essential tremor.
Potent CNS depressant; long-term vitamin D supplementation may be needed. Lists folates among co-treatments requiring attention; megaloblastic anemia can respond to folic acid/B12. St John’s wort is listed under contraindicated co-use because primidone concentrations and effectiveness may decrease. Maternal vitamin K1 is advised near delivery.
How this applies: Exact primidone label supports ingredient-specific boundaries rather than inference solely from phenobarbital metabolism.
Does not quantify botanical interactions or make parent and metabolite concentrations equivalent. Maternal vitamin K guidance differs from evidence reviews. No universal supplement spacing.
Source 3: original clinical research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 2730 treated and 170 untreated epilepsy patients plus 200 healthy controls.
Primidone was among drugs associated with lower folate; phenobarbital was named for lower B12, not lower folate, in the abstract. Replacement corrected vitamin values in most deficient patients.
How this applies: Apply only to the named drugs and study exposures; no unmeasured parent/metabolite or preparation equivalence.
Observational and mixed-treatment results; not proof that phenobarbital lowers folate in every user or that every primidone user needs a supplement. Biochemical improvement is not proof of seizure or cognitive benefit.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Exact current available claims reviewed against captured originals; no clinical review asserted. | |
| Research summary published |
Article revision: 26a85dc712fee5f7
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.